OncoIndx offers Comprehensive Genomic Profiling (CGP) across all Solid Tumors. It is a well-validated NGS test to extract therapy information from both tissues as well as blood samples with a Faster Turn Around Time of less than 15 days. 

        Test Highlights

• 1000+ Genes: Covers over 1000 targetable or therapeutically significant genes.
• High Coverage: Achieves >99% on-target coverage to ensure comprehensive analysis. 
• Mean Depth: With depths of 2000x for tissue and 10000x for blood samples, we ensure thorough examination.
  
  Genomic Markers Covered 
  
  
• 300 Resistance Markers 
• 50 Translocations (fusions) 
• Genome-wide CNV backbone 
• Genome-wide LOH markers 
• 47 HRR genes 
• Genome-wide HRD scoring (based on an aggregate of LOH, LST, TAI and HRR) MSI (including 2000 
• MSI and MMR genes) 
• 18 Pharmacogenomic markers 
• TMB (Tumor Mutational Burden)
  
  What sets us apart? 
  
  
• Longitudinal monitoring markers  
• Traceability to ongoing clinical trials worldwide  
• PD-L1 through IHC (TBx) / immunofluorescence on CTCs (LBx) CTC enumeration